The UCSD CFAR Clinical Investigation Core promotes translational, epidemiologic, and outcomes research in HIV disease by providing access to an established and successful infrastructure. The objectives of the Core are as follows: (1) provide the services, expertise, and environment necessary for clinical investigation and translational research;(2) provide access to a longitudinal database for epidemiologic, behavioral, and outcomes research;(3) foster communication and collaboration between basic and clinical investigators in academics and industry;(4) support training of junior HIV investigators and education of medical personnel;and (5) provide education and awareness of HIV-related research opportunities and CFAR research findings to all HIV-infected individuals, including women and minorities. To meet these objectives, the resources of a large, well-established clinical trials unit are made accessible to a broad range of clinical investigators for pilot and funded projects. Physicians, basic scientists, pharmacists, fellows, junior faculty, and students use Core services. The Core has also processed requests from academic institutions outside UCSD. The Core provides a full range of services, including patient outreach and recruitment;specimen collection;data collection, entry, and analysis;trial design consultation;training of clinical research personnel;and access to a longitudinal, 5,000-patient database containing cumulative clinical, behavioral, and laboratory indicators for epidemiologic- and outcomes-related research. In addition, the Core Directors and affiliated experienced investigators mentor junior investigators and participate in CFAR didactic courses in clinical research methods and biostatistics. The opportunities for outcomes and translational work have been expanded with the CNICS (CFAR Network of Integrated Clinical Systems) project, a collaboration of seven CFAR sites with electronic medical records databases. Core personnel have facilitated the addition of resistance data to the CNICS cohort. In addition, the Core supports an extensive community outreach and education program, which includes concerted efforts to reach women, minorities, and injection drug users. CFAR support of the Clinical Investigation Core has enabled the development of new funded programs, scientific collaborations, and numerous abstracts and publications. Future plans include (1) expanding outcome, resistance and translational research through the CNICS collaboration;(2) expanding the Core's current database to include patient-based measures and enhanced quality assurance of data elements; and (3) fostering multidisciplinary research in the many complications and co-infections that accompany

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-17
Application #
8080819
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
17
Fiscal Year
2010
Total Cost
$280,519
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications